Infection led to a significant increase in the number of mitochondrial ROS-positive cells, which was reversed significantly by itaconate and citraconate, whereas ROS reduction by mesaconate was only marginally significant (Fig. 2f ).
← all excerpts
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism.
1
—
—